In Myasthenia Gravis, Antibodies Pass Open-Label Tests
Researchers presented data from an open-label extension study following the phase 3 MycarinG trial of rozanolixizumab and the ADAPT-SC+ study of efgartigimod.
Source: medscape.com
Item Questionnaire News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Item Questionnaire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Item Questionnaire Today - Breaking & Trending Today
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases
Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...
Source: investingnews.com